Skip to content

The Peptide Problem | Essential: The Pharmacy Compounding Podcast

Pharmacy Podcast Network

33m
Transcript

Original podcast

Where to listen

About this episode

In this edition of Essential, we’ve got concerns about the FDA’s revolving door, some issues with a new California law that might affects the whole country, and a new accreditation that might save a lot of headache. Then we take a deep dive into the once and future world of compounded peptides — where they are, and where they might be going … and why. LinksFDA’s revolving door: https://archive.ph/oxBXP Join APC today: https://a4pc.org/membership Coalition for Compounding Excellence (CCE) accreditation: https://414uue.share-na2.hsforms.com/2n_hRAnRSQ4O8VteGTesF0Q?_hsenc=p2ANqtz-9rfyq3GuFFZw6omRa96tq_es549FWmjiw-sP5NU3LKrsL1eump-l18h7xVrvy8G_V1Pi4UFkfhARMnPCLIx7TBOwPClQ&_hsmi=394109070Pharma Source Direct: https://www.linkedin.com/company/pharma-source-direct/

Transcript

0:00
33:45

5,483 words · 4 speakers

Page updated · transcript and summary are machine-generated